Literature DB >> 22920376

Primary angiosarcoma of the spleen as depicted on computed tomography.

Rui Qi1, Jian-Qun Yu, Huan Xu, Xiang-Ping Zhou, Xue-Ming Li.   

Abstract

Primary angiosarcoma of the spleen is rare, usually widespread or has a splenic rupture by the time of presentation, and almost always has poor prognosis; early radiological diagnosis is necessary for improving the survival rate. We report two special cases of this disease. Both patients did not have pathologic metastasis or splenic rupture, but their computed tomography (CT) manifestations were distinct from each other and had uncommon characteristics. We compared the CT features with pathological findings.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22920376     DOI: 10.1016/j.clinimag.2011.12.016

Source DB:  PubMed          Journal:  Clin Imaging        ISSN: 0899-7071            Impact factor:   1.605


  4 in total

1.  Delayed diagnosis of angiosarcoma of the spleen: clinically presenting as recurrent haemoperitoneum following embolisation.

Authors:  Verena Kornmann; Philip van Rijn; Dries Mulder; Koen Reijnders
Journal:  BMJ Case Rep       Date:  2015-04-09

Review 2.  Angiosarcoma: clinical and imaging features from head to toe.

Authors:  Ayman H Gaballah; Corey T Jensen; Sarah Palmquist; Perry J Pickhardt; Alper Duran; Gregory Broering; Khaled M Elsayes
Journal:  Br J Radiol       Date:  2017-05-04       Impact factor: 3.039

3.  Well-differentiated angiosarcoma of spleen: a teaching case mimicking hemagioma and cytogenetic analysis with array comparative genomic hybridization.

Authors:  Lichen Xu; Yimin Zhang; Hong Zhao; Qingxiao Chen; Weihang Ma; Lanjuan Li
Journal:  World J Surg Oncol       Date:  2015-10-13       Impact factor: 2.754

4.  Treatment with sorafenib plus camrelizumab after splenectomy for primary splenic angiosarcoma with liver metastasis: A case report and literature review.

Authors:  Dan Pan; Tai-Ping Li; Jian-Hui Xiong; Shu-Bo Wang; Yao-Xu Chen; Jian-Feng Li; Qi Xiao
Journal:  World J Clin Cases       Date:  2022-03-26       Impact factor: 1.337

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.